Keywords
aging
skin
cutaneous mycoses
immunosenescence
How to Cite
Abstract
This article addressed Alzheimer's disease (AD) as the most common cause of dementia and a global health problem, characterized by progressive cognitive decline, loss of autonomy, and a high family and social impact. Its historical evolution and current definition as a specific neuropathological entity, associated with the presence of senile plaques and neurofibrillary tangles with temporoparietal predominance, were described. The epidemiological magnitude of AD was analyzed in the context of population aging, highlighting its growing prevalence and projections of increase in middle- and low-income countries. Likewise, its clinical manifestations, both cognitive and behavioral, were reviewed, and its multifactorial etiology, involving genetic, vascular, metabolic, environmental, and infectious factors, was discussed. In particular, emerging hypotheses linking inflammatory processes, bacterial, viral, and fungal infections, oxidative stress, and alterations in the microbiota with neurodegenerative mechanisms were explored. Taking a comprehensive approach, the study expanded the analysis to include the skin as a barrier and immunoregulatory organ, describing the structural, functional, and immunological changes characteristic of skin aging. It examined how these changes, together with immunosenescence, malnutrition, comorbidities, and self-care difficulties present in patients with AD, increased susceptibility to skin infections, especially superficial mycoses. The study integrated knowledge from neurology, dermatology, and immunology, allowing us to infer that people with AD were more predisposed to skin pathologies compared to the population without dementia. Finally, the importance of an interdisciplinary approach aimed at prevention, early detection, and comprehensive management was highlighted, with the aim of improving the quality of life and overall care of these patients.
References
1. Alburquenque C, Tapia C. Interacción Candida albicans-hospedero: un proceso complejo en el que la inmunidad innata juega un importante papel. Bol Micol. 2013;28(2):37-47.
2. Allegri R, Arizaga R, Bavec C, Colli L, Demey I, Fernández M, et al. Enfermedad de Alzheimer. Guía de práctica clínica. Buenos Aires: Elsevier; 2010.
3. Alves R, Castro Esteves TM. Factores intrínsecos y extrínsecos implicados en el envejecimiento cutáneo. Cir Plást Ibero-Latinoam. 2013;39(1):89-102.
4. Alzheimer A. Acerca de una enfermedad singular de la corteza cerebral. Rev Neuropsiquiatr. 1995;58(3):147-149.
5. Asociación Americana de Psiquiatría. Actualización de la codificación del DSM-5. Suplemento del Manual diagnóstico y estadístico de los trastornos mentales. Madrid: Masson; 2014.
6. Bautista Meneses R. Inmunología de piel. Disponible en: https://es.slideshare.net/randijesus/inmunologia-de-piel
7. Becerra Manrique A, Preciado M, Riaño G, Sierra G. Microbiota de la piel: identidad de cada individuo. Biociencias. 2017;2:53-59.
8. Bello Díaz R, Pascual C, Bello Llinas R, Andújar B, Cuadrado J. Microbiota: un nuevo órgano del cuerpo humano. Disponible en: https://slideplayer.es/slide/12045009/
9. Buendía Eisman A, Mazuecos Blanca J, Camacho Martínez F. Anatomía y fisiología de la piel. En: Conejo Mir J, Moreno Jiménez J, Camacho Martínez F, editores. Manual de Dermatología. Barcelona: Aula Médica; 2018. p. 2-27.
10. Buentke E, Heffler L, Wallin P, Löfman C, Ljunggren G, Scheynius A. The allergenic yeast Malassezia furfur induces maturation of human dendritic cells. Clin Exp Allergy. 2008;31(10):1583-1593.
11. Carrillo E, Carrillo C, Carrillo L, Carrillo A. Alteraciones ungueales como marcador de enfermedad sistémica. Med Interna Mex. 2010;26(3):243-249.
12. Castellanos Aguilar L, Martínez Zúñiga N, Gutiérrez Murcia JV, Garcés Ramírez L, De la Cruz F, Guadarrama Ortiz P, et al. La tinción con el colorante rojo tiazina como método diagnóstico post mortem rápido y confiable para la enfermedad de Alzheimer. Arch Neurocienc. 2017;26(3):243-249.
13. Castillo Sánchez J. Estrés oxidativo y neurodegeneración: antioxidantes y Alzheimer. Disponible en: https://www.um.es/lafem/Actividades/OtrasActividades/CursoAntioxidantes/MaterialAuxiliar/2012-02-14-AlzheimerAntioxidantes.pdf
14. Cerquera Jaramillo M, Nava Mesa M, González Reyes R, Téllez Conti C, De la Torre A. Visual features in Alzheimer’s disease: from basic mechanisms to clinical overview. Neural Plast. 2018;2941783.
15. Clarke R, Smith AD, Jobst KA. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449-1455.
16. Comesaña A, González M. Evaluación neuropsicológica en la enfermedad de Alzheimer: memoria episódica y semántica. Cuad Neuropsicol. 2009;3(2).
17. Czepita D, Kuzná-Gygiel W, Czepita M, Grobelny A. Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis. Ann Acad Med Stetin. 2007;53(1):63-67.
18. Dahl MV. Dermatophytosis and the immune response. J Am Acad Dermatol. 1994;30:S34-S41.
19. Davel G, Canteros CE. Situación de las micosis en la República Argentina. Rev Argent Microbiol. 2007;39:28-33.
20. de Hoog GS, Monod M, Dawson TL, Boekhout T, Mayser P, Gräser Y. Skin fungi: from colonization to infection. Microbiol Spectr. 2017;5(4).
21. de Oliveira CB, Vasconcellos C, Sakai Valente NY, Sotto MN, Guedes Luiz F, Belda Júnior W, et al. Toll-like receptors 2 and 4 expression of keratinocytes from patients with localized and disseminated dermatophytosis. Rev Inst Med Trop Sao Paulo. 2015;57(1):57-61.
22. de Plessis J, Stefaniak A, Wilhelm KP. Measurement of skin surface pH. En: Surber C, Abels C, Maibach H, editores. Current Problems of Dermatology. Vol 54. Basel: Karger; 2018. p. 19-25.
23. Duyckaerts C, Lowe J, Frosch MP. Pathology of degenerative diseases of the nervous system. En: Gray F, Duyckaerts C, De Girolami U, editores. Escourolle & Poirier’s Manual of Basic Neuropathology. Oxford: Oxford University Press; 2016.
24. Elston DM. Demodex mites: facts and controversies. Clin Dermatol. 2010;28(5):502-504.
25. Farage MA, Miller KW, Elsner P, Maibach HI. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol. 2007;26(4):343-357.
26. Fernández de Moya E. Demencias e imagen: lo básico. Radiología. 2010;52(1):4-17.
27. Folstein M, Charman M. Nutrition and Alzheimer’s disease. Nutr Rev. 2009;55(1):23-25.
28. Forbes WF, Hill GB. Is exposure to aluminum a risk factor for the development of Alzheimer disease? Arch Neurol. 1998;55(5):740-741.
29. Forero Ortiz FC. Enfermedad de Alzheimer desde el punto de vista neurológico y molecular. Bogotá: Universidad Distrital Francisco José de Caldas; 2018.
30. Gaitanis G, Velegraki A, Mayser P, Bassukas ID. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin Dermatol. 2013;31(4):455-463.
31. Gao Z, Pérez-Pérez GI, Chen Y, Blaser MJ. Quantitation of major human cutaneous bacterial and fungal populations. J Clin Microbiol. 2010;48(10):3575-3581.
32. García-Vidal C, Salavert Lletí M. Inmunidad frente a hongos: mecanismos de evasión de la respuesta inmune. Rev Iberoam Micol. 2014;31(4):219-228.
33. Gibson RS. Principles of nutritional assessment. New York: Oxford University Press.
34. Gragnani A, Mac Cornick S, Chominski V, Ribeiro de Noronha S, Alves Correa de Noronha S, Ferreira LM. Review of major theories of skin aging. Adv Aging Res. 2014;3(4).
35. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244-253.
36. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups. Alzheimers Dement. 2011;7(3):263-269.
37. Hahnel E, Lichterfeld A, Blume-Peytavi U, Kottner J. The epidemiology of skin conditions in the aged: a systematic review. J Tissue Viability. 2017;26(1):20-28.
38. Harada K, Saito M, Sugita T, Tsuboi R. Malassezia species and their associated skin diseases. J Dermatol. 2015;42(3):231-268.
39. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51(Suppl 4):2-15.
40. Holmes C, Plichta J, Gamelli R, Radek K. Dynamic role of host stress responses in modulating the cutaneous microbiome: implications for wound healing and infection. Adv Wound Care (New Rochelle). 2015;4(1):24-37.
41. Hopkins B. Assessment of nutritional status. En: Gottschlich MM, editor. Nutrition support dietetics core curriculum. Silver Spring (MD): ASPEN; 1993.
42. Huang Y, Mucke L. Alzheimer’s disease mechanisms and therapeutic strategies. Cell. 2012;148:1204-1222.
43. Iram N, Mildner M, Prior M, Petzelbauer P, Fiala C, Hacker S, et al. Age-related changes in expression and function of toll-like receptors in human skin. Development. 2012;139(22):4210-4219.
44. Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno Palop C. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;50:1-15.
45. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.
46. Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA. Systemic manifestations of Alzheimer’s disease. Acta Ophthalmol. 2017;95(8):668-676.
47. Lacey N, Kavanagh K, Tseng SCG. Under the lash: Demodex mites in human diseases. Biochemist. 2009;31(4):2-6.
48. Lai-Cheong JE, McGrath JA. Structure and function of skin, hair and nails. Medicine (Abingdon). 2017;45(6):347-352.
49. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28(5):359-370.
50. López Álvarez J, Agüera Ortiz L. Nuevos criterios diagnósticos de la demencia y la enfermedad de Alzheimer: una visión desde la psicogeriatría. Psicogeriatría. 2015;5(1):9.
51. Maheshwari P, Eslick GD. Bacterial infection and Alzheimer’s disease: a meta-analysis. J Alzheimers Dis. 2015;43(3):957-966.
52. Martín B. Histopatología de la uña. Actas Dermosifiliogr. 2013;104(7):567-578.
53. Martínez-Lage P, Manzano Palomo MS, García Ribas G. Know Alzheimer: respuestas concretas a dudas reales. Manual de consulta para neurólogos. Barcelona: STADA–Profármaco.
54. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939-944.
55. Mena López R, Luna Muñoz J, Gómez Sánchez F, Hernández Alejandro M. Histopatología molecular de la enfermedad de Alzheimer. México: DGSCA, UNAM.
56. Mong F, Laconte L, Casero R. Ácaros del género Demodex: ¿parásitos colonizadores de personas sanas o asociados a patología ocular? Rev Argent Microbiol. 2018;50(4):369-373.
57. Moran JA, Hogan M, Srsic-Stoehr K, Service K, Earle-Hahn J. Enfermedad de Alzheimer y síndrome de Down. New York: National Down Syndrome Society.
58. Muñoz DG. Is exposure to aluminum a risk factor for the development of Alzheimer disease? Arch Neurol. 1998;55(5):737-739.
59. Narangifard A, den Hollander L, Wennberg CL, Lundborg M, Lindahl E, Iwai I, et al. Human skin barrier formation takes place via a cubic-to-lamellar lipid phase transition as analyzed by cryo-electron microscopy and EM simulation. Exp Cell Res. 2018;366(2):139-151.
60. Navarrete Franco G. Histología de la piel. Rev Fac Med UNAM. 2003;46(4).
61. Nazar J, Gerosa P, Díaz O. Onicomicosis: epidemiología, agentes causales y evaluación de los métodos diagnósticos de laboratorio. Rev Argent Microbiol.
62. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol. 2009;9(10):679-691.
63. Pardi P, Santos G, Silva Gois J, Braz R Jr, Olave E. Biomarcadores y marcadores de imagen de la enfermedad de Alzheimer. Int J Morphol. 2017;35(3):864-869.
64. Reisberg B, Burns A, Brodaty H. Diagnosis of Alzheimer’s disease: report of an International Psychogeriatric Association Special Meeting Work Group. Int Psychogeriatr. 1997;9(Suppl 1):11-38.
65. Relloso S, Arechavala A, Guelfand L, Maldonado I, Walker L, Agorio I, et al. Onicomicosis: estudio multicéntrico clínico, epidemiológico y micológico. Rev Iberoam Micol. 2012;29(3):157-163.
66. Reyes Suro J, Gutiérrez Fernández L. El pelo: generalidades y funciones. Dermatol CMQ. 2007;5(4):218-223.
67. Richardson JP, Moyes DL. Adaptive immune responses to Candida albicans infection. Virulence. 2015;6(4):327-337.
68. Richmond JM, Harris JE. Immunology and skin in health and disease. Cold Spring Harb Perspect Med. 2014;4(12).
69. Sahoo A, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J. 2016;7(2):77-86.
70. Sanabria Castro A, Alvarado Echeverría I, Monge Bonilla C. Estrategias terapéuticas en la enfermedad de Alzheimer. Rev Neurobiol. 2016;7(15).
71. Sánchez Saldaña L. El sistema inmunológico cutáneo. Dermatol Perú. 2011;21(2):57-58.
72. Seebacher C, Bouchara JP. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008;166(5-6):335-352.
73. Segovia de Arana JM, Mora Teruel F. Enfermedades neurodegenerativas. Madrid: Farmaindustria.
74. Seneschal J, Clark RA, Gehad A, Baecher-Allan C, Kupper TS. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating resident regulatory T cells. Immunity. 2012;36(5):873-884.
75. Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol. 1983;80(1):12-16.
76. Suay Llopis L, Ballester Díez F. Revisión de los estudios sobre exposición al aluminio y enfermedad de Alzheimer. Rev Esp Salud Publica. 2002;76(6):645-658.
77. Tounsi H, Deweer B, Ergis AM, Van der Linden M, Pillon B, Michon A. Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord.
78. Vega Prieto E. Importancia del diagnóstico precoz en la enfermedad de Alzheimer: marcadores preclínicos y prodrómicos. Sevilla: Universidad de Sevilla.
79. Vena GA, Chieco P. Epidemiology of dermatophytoses: retrospective analysis from 2005 to
80. Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF. Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer’s disease patients. J Med Virol. 2005;75(2):300-306.
81. Xia S, Zhang X, Zheng S, Khasnabdali R, Kalionis B, Wu J, et al. An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res. 2016;8426874.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Fabián Ignacio Tuysuz Galvez, Teodoro Yacoubian (Author)